α-GalCer analog 8 – 500 µg

Brand:
Cayman
CAS:
922727-14-8
Storage:
-20
UN-No:
Non-Hazardous - /

α-Galactosylceramide analog 8 (α-GalCer analog 8) is a triazole derivative of α-galactosylceramide.{42588} It increases IL-2 secretion by DN32.D3 NKT hybridoma cells when co-cultured with CD1d-transfected RBL cells pre-loaded with α-GalCer analog 8 at a concentration of 32 ng/ml. α-GalCer analog 8 (32 ng/ml) induces IL-4 secretion to a greater extent than the synthetic α-GalCer KRN 7000 (Item No. 11208) in mouse splenocytes in vitro and in mouse serum following administration of a 1 µg per animal dose, indicating a Th2 response.  

 

Available on backorder

SKU: 26660 - 500 µg Category:

Description

A triazole α-GalCer derivative; increases IL-2 secretion by DN32.D3 NKT hybridoma cells when co-cultured with CD1d-transfected RBL cells pre-loaded with α-GalCer analog 8 at 32 ng/ml; induces IL-4 secretion to a greater extent than the synthetic α-GalCer KRN 7000 in mouse splenocytes in vitro and in mouse serum following administration of a 1 µg per animal dose


Formal name: (2S,3S,4R)-3,4-dihydroxy-2-(4-tetracosyl-1H-1,2,3-triazol-1-yl)octadecyl, α-D-galactopyranoside

Synonyms:  α-Galactosylceramide analog 8

Molecular weight: 868.3

CAS: 922727-14-8

Purity: ≥95%

Formulation: A solid


Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Sphingolipids